The FDA did not respond to a request for comment. U.S. Health Secretary Robert F. Kennedy Jr. has said that the agency's ...

Recent health news covers significant actions including Senator Warren's call for ethics in health appointments, President ...

Kyverna Therapeutics may consider it had an “exceptional start to the year,” but that didn’t immunize the cell therapy ...

With long development timelines and high burn rates, biotech companies must navigate capital markets with precision.

For the quarter ended March 31, 2025, Edesa reported a net loss of $1.6 million, or $0.30 per common share, compared to a net loss of $1.9 million, or $0.58 per common share, for the quarter ended ...

Executives also cite NIH and FDA uncertainty, external reference pricing, tariffs, and research funding cuts as major threatsWashington, DC, May 08, 2025 (GLOBE NEWSWIRE) -- A new survey conducted by ...

On April 23, 2025, the Company announced that three abstracts on Versamune® HPV (PDS0101) were selected for presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, to be ...

The VanEck Biotech ETF offers lower risk with established companies, but 23% of AUM in speculative stocks poses a risk. Check ...

DUBLIN, March 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...